Vitamin D Levels among Hospitalized and Non-Hospitalized COVID-19 Patients in Dr. M. Djamil General Hospital Padang


  •   Harika Putra

  •   Efrida

  •   Rismawati Yaswir


Coronavirus Disease 2019 (COVID-19) causes immune system dysregulation and an exaggerated systemic inflammatory response. Vitamin D acts as an immunomodulator that enhances the immunity defense. Low levels of vitamin D affect the severity of COVID-19 infection. This study aims to determine vitamin D levels in hospitalized and non-hospitalized COVID-19 patients. A case-control study was conducted involving 62 COVID-19 patients, equally divided into hospitalized and non-hospitalized groups at RSUP dr. M. Djamil, Padang from February to September 2020. Serum vitamin D levels were measured using the Chemiluminescent Microparticle Immunoassay. Vitamin D deficiency was defined as a level less than 20 ng/mL. The hospitalized group consisted of moderate to critical COVID-19 patients, whereas the non-hospitalized group consisted of the asymptomatic and mild COVID-19 patients according to the Indonesian Ministry of Health Guidelines. All data were analyzed using a T-test and Chi-square with a significant p-value of 0.05. The results showed that most subjects were women between 21–60 years. The mean level of vitamin D (ng/mL) in the hospitalized group was lower than in the non-hospitalized group (15.5 ± 7.72 vs. 19.2 ± 14.30; 95% CI -9.509–2.167; p=0.213). Vitamin D deficiency affected hospitalized group more than the non-hospitalized group, but not statistically significant (71% vs. 64.5%, p=0.566). It indicated the role of vitamin D in preventing immune system hyperactivation causing COVID-19 cytokine storm. This study concluded no difference in vitamin D levels among the study groups. Nevertheless, further research on vitamin D is needed to determine its role and benefits against COVID-19 infection.

Keywords: COVID-19, cytokine storm, inflammation, vitamin D deficiency


Ali N. Role of vitamin D in preventing of COVID-19 infection, progression, and severity. Journal of Infection and Public Health. 2020; 13(10): 1373–1380.

Turrubiates‑Hernández FJ, Sánchez‑Zuno GA, González‑Estevez G, Hernández‑Bello J, Macedo‑Ojeda G, Muñoz‑Valle JF. Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review). International Journal of Molecular Medicine. 2021; 47(4): 32.

Cutolo M, Paolino S, Smith V. Evidence for a protective role of vitamin D in COVID-19. RMD Open. 2020; 6: e001454.

Pusparini. Defisiensi vitamin D terhadap penyakit. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2014; 21(1): 90–95. Indonesian.

Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Berisha AT, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. European Journal of Clinical Nutrition. 2020; 74: 1498–1513.

Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology. 2011; 134(2): 123–139.

Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Frontiers in Immunology. 2017; 7: 697.

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020; 12(4): 988.

Annweiler G, Corvaisier M, Gautier J, Dubée V, Legrand E, Sacco G, et al. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients. 2020; 12(11): 3377.

Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, et al. High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study. Nutrients. 2020; 12(12): 3799.

Raharusuna P, Priambada S, Budiarti C, Agung E, Budi C. Patterns of COVID-19 mortality and vitamin D: an indonesian study. SSRN Electronic Journal. 2020: 1-14.

Macaya F, Espejo C, Valls A, Ortiz AF, Castillo JG, Martin J, et al. Interaction between age and vitamin D deficiency in severe COVID-19 infection. Nutricion Hospitalaria. 2020; 37(5): 1039–1042.

Kementerian Kesehatan Republik Indonesia. Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19) revisi Ke-5. Kementerian Kesehatan Republik Indonesia. Jakarta. 2020; 1–214. Indonesian.

Edis Z, Bloukh SH. Vitamin D deficiency: main factors affecting the serum 25-hydroxyvitamin d ([25(OH)D]) status and treatment options. International Journal of Research. 2016; 3(1): 197–210.

Abbott Laboratories. Architect 25-OH Vitamin D, B5P020 25-OH Vitamin D 5P02 G5-6832/R03e, Lake Forest, Illinois, USA. 2020:1–8.

Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020; 287(17): 3693–3702.

Pinzon RT, Angela, Pradana AW. Vitamin D deficiency among patients with COVID-19: case series and recent literature review. Troical Medical Health. 2020; 48: 102.

Hastie CE, Pell JP, Sattar N. Vitamin D and COVID-19 infection and mortality in UK Biobank. European Journal of Nutrition. 2021; 60(1): 545–548.

Hernández JL, Nan D, Fernandez-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. Journal of Clinical Endocrinology & Metabolism. 2021; 106(3): e1343-e1353.

Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. 2020; 12(9): 2757.

Wang MX, Gwee SXW, Pang J. Micronutrients deficiency, supplementation and novel coronavirus infections-a systematic review and meta-analysis. Nutrients. 2021; 13(5): 1589.

Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Journal of Pathology. 2020; 251(3): 228–248.

Efrida, Yaswir R, Rofinda ZD. Hubungan vitamin D dengan kadar adiponektin, Hs-CRP, dan profil lipid pada subjek berat badan berlebih di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas. 2018. Indonesian.


Download data is not yet available.


How to Cite
Putra, H., Efrida, & Yaswir, R. . (2021). Vitamin D Levels among Hospitalized and Non-Hospitalized COVID-19 Patients in Dr. M. Djamil General Hospital Padang. European Journal of Medical and Health Sciences, 3(6), 78–81.